Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer

Cardiovascular diseases may determine therapy outcomes of non-small-cell lung cancer (NSCLC). The evidence for how iatrogenic cardiovascular complications contribute to ceasing anticancer treatment, decreasing the quality of life or even premature death, is unclear. Older patients and smokers are at...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaborowska-Szmit, Magdalena, Krzakowski, Maciej, Kowalski, Dariusz M., Szmit, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287714/
https://www.ncbi.nlm.nih.gov/pubmed/32349387
http://dx.doi.org/10.3390/jcm9051268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287714/
https://www.ncbi.nlm.nih.gov/pubmed/32349387
http://dx.doi.org/10.3390/jcm9051268

Ejemplares similares